Miles W. Griffis

This artist is memorializing the Covid-19 pandemic through textiles, and you can help

Arts & Culture, Health

·

By

Miles W. Griffis

–

January 30, 2024

A blue stitch for a case. A red stitch for a death. At the start of the Covid-19 pandemic, Boulder-based artist Heather Schulte wanted to turn the case and death tallies into something tangible. She had grown up in Nebraska and had been “embedded in textiles since birth,” she said. As the virus spread, she…
Research updates, January 30

Science

·

By

Miles W. Griffis

–

January 30, 2024

Research updates for the week of January 30 include news from NIH RECOVER’s observational studies, cognitive slowing among people with Long Covid, and health issues that arise in infants whose mothers have Covid-19.
Research updates, January 23

Science

·

By

Miles W. Griffis

–

January 23, 2024

Research updates for the week of January 23 include issues in the blood proteins of people with Long Covid, a potential mechanism for neurological symptoms, and preventative measures for Covid-19.
Social media users ask, “Where is Mandy?” as CDC director stays out of spotlight during Covid surge

COVID-19, Policy & Advocacy

·

By

Miles W. Griffis

–

January 16, 2024

Despite what might be the second biggest surge of the entire pandemic, CDC director Mandy Cohen has been absent from her official CDC social media accounts. Similarly, the CDC has yet to issue any press releases or public service announcements specifically about the JN.1 surge, which may be infecting over one million Americans each day…
Research updates, January 16

Science

·

By

Miles W. Griffis

–

January 16, 2024

New research for the week of January 16 include a study examining viral persistence in people with Long Covid, the link between Epstein-Barr virus and Multiple Sclerosis, and a therapy used for chest pain that may have Long Covid applications.
What’s happening this week, January 9

Policy & Advocacy, Science

·

By

Miles W. Griffis

–

January 9, 2024

A new study in Nature Communications confirms what so many people with post-exertional malaise (PEM) have been saying for decades: exercise can make us worse. Plus: research about Paxlovid and returning to work, an upcoming march in DC, an important NIH webinar.
Long Covid advocates send “unhappy holiday” cards to their representatives

Policy & Advocacy

·

By

Miles W. Griffis

–

December 26, 2023

This month, the organizers of Long Covid Moonshot put together an “Unhappy Holidays” card, letter, and calling campaign directed at legislators. Some from the international community joined in too, writing cards to their respective governments. The creative effort featured colorful, funny, and heartbreaking letters from people with Long Covid and their allies to advocate for…
#MEAction co-founder Beth Mazur passes away

Policy & Advocacy

·

By

Miles W. Griffis

–

December 26, 2023

On Friday, the ME advocacy group #MEAction shared that their co-founder, Beth Mazur, passed away after living with myalgic encephalomyelitis (ME) for 15 years. “She was a selfless beacon of hope and light for so many in our community and she demonstrated an unwavering commitment to the cause,” #MEAction wrote on their website.
Policy experts, scientists, disability groups urge Biden to address the Long Covid crisis

Policy & Advocacy

·

By

Miles W. Griffis

–

December 18, 2023

A wide breadth of policy experts, scientists, and disability groups are calling on President Biden to urgently address the Long Covid crisis with annual funding in the billions. In the open letter published on Monday, health policy experts, leading Long Covid researchers, clinicians, journalists, chronic illness and health advocacy groups, and many others demand that…
Virtual town hall recording now available

Commentary

·

By

Miles W. Griffis

–

December 12, 2023

Thanks to everyone who came to our virtual town hall last week! We received incredible feedback, comments, and story ideas from the community. A recording of the first few minutes of the meeting, featuring an overview and update from our co-editors, is now available.